Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Brio Pharmaceuticals Inc
483
•Brio Pharmaceuticals Inc•February 27, 2026

Brio Pharmaceuticals Inc – FDA 483, Feb 27, 2026

Record Details

Brio Pharmaceuticals Inc., a prescription drug manufacturer located in Houston, Texas, underwent a regulatory inspection by the FDA from February 23 to February 27, 2026. The inspection identified several critical deficiencies in the facility"s adherence to required manufacturing standards. Specifically, the firm failed to provide mandatory annual training on Good Manufacturing Practices to its employees and temporary workers during 2024 and 2025. Additionally, the quality control unit did not consistently apply quarantine or approval labels to material containers and pallets, leading to potential confusion regarding the status of raw materials. Investigators also discovered that the company failed to follow its own stability testing protocols. Temperature mapping studies, which ensure uniform environmental conditions, had not been conducted for specific stability chambers used to test drug solutions. These observations were issued under the Federal Food, Drug, and Cosmetic Act to highlight practices that deviate from safety and quality regulations. While these findings do not constitute a final agency determination, the company is required to address these issues by discussing corrective actions with the FDA or submitting a formal written response outlining their plan for remediation.

Company
Brio Pharmaceuticals Inc
Inspection date
February 27, 2026
Product type
drugs
Office
Dallas District Office
Person
  • Timothy H. Vo (investigator)
View Company Profile

ID · c856e38d-3f53-4629-82c6-a83eee99d45b

Other documents for Brio Pharmaceuticals Inc
  • 483 - 2020-01-24January 24, 2020
  • 483 - 2019-07-11July 11, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Brio Pharmaceuticals Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.